Company
Remi Meds
Remi Meds publishes unspecified GLP-1 at $249 a month — Personalized GLP-1, 0.25-0.5 mg/week (starting dose).
- 1 program
- 1 molecule
- 1 reading
Read from remimeds.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Remi Meds
We earn nothing from this link. Remi Meds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Personalized GLP-1, 0.25-0.5 mg/week (starting dose)
Terms
| Pharmacy | Strive Pharmacy, Gilbert AZ |
|---|
Not yet checked: membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Site never names semaglutide or tirzepatide specifically — the two products are called 'Personalized GLP-1' and 'Personalized GLP-1/GIP +B12', described only as a 'custom-formulated version of the medication used for blood sugar control'; recorded as unspecified GLP-1 rather than inferring compounded semaglutide/tirzepatide. FAQ says orders 'cannot be changed or cancelled once submitted' while the Returns and Refunds page says you can cancel your subscription before it ships — the two pages contradict each other on cancellation.
Before you act
Cite this
Treatment Registry. (2026). Remi Meds: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/remi-meds